EIF3C and neoplasm: Iacs-eif3c-RNA inhibited tumor growth (TGI=56.18%) with little impact on body weights, while the combined treatment showed tumor growth inhibition (TGI=42.53%) accompanying body weight decline (Figures 6E, F).